Building World-Changing Businesses

StemBond Technologies is redefining the potential of cell culture with advanced materials science. They offer precise, mechanically tuned cell culture

Koalaa is developing the next generation of prosthetics and orthotics for people with upper limb differences. The Imperial College London spin-out has

Concr is a value-driven techbio company, spun out of the University of Cambridge, applying statistical learning and advanced modelling adopted from as

Zomp is a University of Cambridge spin-out which is building the world’s first 3D imaging cytometer and cell sorter. This new 3D imaging cytometry w

Enhanc3D Genomics is developing a proprietary technology that simultaneously profiles 3D genome folding at high resolution for all genes and their enh

Spirea is developing the next generation of Antibody-Drug Conjugate (ADC) drugs for cancer treatment. The company have designed a novel, wholly owned

NK:IO is an Imperial spinout developing small molecule and cell-mediated immunotherapy for the treatment ofcancer. The company is developing technique

SERG Technologies is developing a connected platform which enables remote, patient-specific assessment of all Parkinson’s disease motor symptoms

Semarion is a University of Cambridge spin-out from the Cavendish Laboratory. The company is commercialising their SemaCyte® technology, a platform t

FreshCheck has developed a novel colour change technology to detect bacterial contamination on surfaces. Surface testing technology is required across